Latest filing published 09 Mar 2026 for Elevance Health, Inc., €784k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Charles Morgan Kendrick Jr. (senior executive) discloses dealings in Elevance Health, Inc. to SEC (Form 4). Between 1 November 2021 and 6 March 2026, the trades on record add up to 37 filings.
On the market, this insider has only sold: 10 sales, €10.1M in total. The rest of the record consists of 23 share grants and 4 option exercises. In 2026 alone, the filings show no purchases and 1 sale.
The newest entry dates from 9 March 2026: an open-market sale of €784k, in Elevance Health, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations